29 related articles for article (PubMed ID: 25818504)
1. SMARTERscreen protocol: a three-arm cluster randomised controlled trial of patient SMS messaging in general practice to increase participation in the Australian National Bowel Cancer Screening Program.
McIntosh JG; Emery JD; Wood A; Chondros P; Goodwin BC; Trevena J; Wilson C; Chang S; Hocking J; Campbell T; Macrae F; Milley K; Lew JB; Nightingale C; Dixon I; Castelli M; Lee N; Innes L; Jolley T; Fletcher S; Buchanan L; Doncovio S; Broun K; Austin G; Jiang J; Jenkins MA
Trials; 2023 Nov; 24(1):723. PubMed ID: 37957680
[TBL] [Abstract][Full Text] [Related]
2. Increasing bowel cancer screening using SMS in general practice: the SMARTscreen cluster randomised trial.
McIntosh JG; Jenkins M; Wood A; Chondros P; Campbell T; Wenkart E; O'Reilly C; Dixon I; Toner J; Martinez-Gutierrez J; Govan L; Emery JD
Br J Gen Pract; 2024 Apr; 74(741):e275-e282. PubMed ID: 38164588
[TBL] [Abstract][Full Text] [Related]
3. Factors of Never Screened with Faecal Occult Blood Test in Public Primary Care Facilities.
Sazali MF; Syed Abdul Rahim SS; Avoi R; Hassan MR; Hayati F; Azhar ZI; Jeffree MS; Awang Lukman K; Oo Tha N; Sajali H; Atil A; Abd Rahim MA
Asian Pac J Cancer Prev; 2021 Jan; 22(1):163-169. PubMed ID: 33507695
[TBL] [Abstract][Full Text] [Related]
4. Institutional (mis)trust in colorectal cancer screening: a qualitative study with Greek, Iranian, Anglo-Australian and Indigenous groups.
Ward PR; Coffey C; Javanparast S; Wilson C; Meyer SB
Health Expect; 2015 Dec; 18(6):2915-27. PubMed ID: 25271975
[TBL] [Abstract][Full Text] [Related]
5. Screening practices of Australian men and women categorized as "at or slightly above average risk" of colorectal cancer.
Ait Ouakrim D; Lockett T; Boussioutas A; Keogh L; Flander LB; Winship I; Giles GG; Hopper JL; Jenkins MA
Cancer Causes Control; 2012 Nov; 23(11):1853-64. PubMed ID: 23011536
[TBL] [Abstract][Full Text] [Related]
6. Cancer Screening among immigrants living in urban and regional Australia: results from the 45 and up study.
Weber MF; Chiew M; Feletto E; Kahn C; Sitas F; Webster L
Int J Environ Res Public Health; 2014 Aug; 11(8):8251-66. PubMed ID: 25153460
[TBL] [Abstract][Full Text] [Related]
7. Testing outside of the National Bowel and Breast Cancer Screening Programs in Queensland, Australia.
Fletcher S; Goodwin BC
J Med Screen; 2024 May; ():9691413241256595. PubMed ID: 38797978
[No Abstract] [Full Text] [Related]
8. The 'hot zone policy' for colorectal cancer screening presents unique risks and opportunities for rural Australia.
Worthington J; Lew JB; He E; Broun K; D'Onise K; Grogan P; Canfell K; Feletto E
Aust J Rural Health; 2023 Jun; 31(3):580-586. PubMed ID: 36912762
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer screening test exposure patterns in US adults 45 to 49 years of age, 2019-2021.
Star J; Siegel RL; Minihan AK; Smith RA; Jemal A; Bandi P
J Natl Cancer Inst; 2024 Apr; 116(4):613-617. PubMed ID: 38177071
[TBL] [Abstract][Full Text] [Related]
10. Testing the Effectiveness of a Primary Care Intervention to Improve Uptake of Colorectal Cancer Screening: A Randomized Controlled Trial Protocol.
Dodd N; Carey ML; Mansfield E; Oldmeadow C
JMIR Res Protoc; 2017 May; 6(5):e86. PubMed ID: 28490420
[TBL] [Abstract][Full Text] [Related]
11. Testing the effectiveness of a general practice intervention to improve uptake of colorectal cancer screening: a randomised controlled trial.
Dodd N; Carey M; Mansfield E; Oldmeadow C; Evans TJ
Aust N Z J Public Health; 2019 Oct; 43(5):464-469. PubMed ID: 31268211
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of appropriate colorectal cancer screening and preferences for receiving screening advice among people attending outpatient clinics.
Dodd N; Mansfield E; Carey M; Oldmeadow C
Aust N Z J Public Health; 2018 Aug; 42(4):334-339. PubMed ID: 29528551
[TBL] [Abstract][Full Text] [Related]
13. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
Quintero E
Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
[TBL] [Abstract][Full Text] [Related]
14. Australia's national bowel cancer screening program: does it work for indigenous Australians?
Christou A; Katzenellenbogen JM; Thompson SC
BMC Public Health; 2010 Jun; 10():373. PubMed ID: 20579344
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of FOB testing in eastern-Australian general practice patients: what has a national bowel cancer screening program delivered?
Paul CL; Carey ML; Russell G; D'Este C; Sanson-Fisher RW; Zwar N
Health Promot J Austr; 2015 Apr; 26(1):39-44. PubMed ID: 25818504
[TBL] [Abstract][Full Text] [Related]
16. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
Todorov K; Wilson C; Sharplin G; Corsini N
Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
